Health Care & Life Sciences » Pharmaceuticals | Daiichi Sankyo Co. Ltd.

Daiichi Sankyo Co. Ltd. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
99,775
79,936
122,388
87,788
81,021
85,831
Depreciation, Depletion & Amortization
51,486
42,023
44,306
47,373
46,680
46,169
Other Funds
1,030
79
1,247
1,038
5,262
26,971
Funds from Operations
37,477
140,317
136,471
135,618
134,815
105,029
Changes in Working Capital
173
2,458
37,810
616
26,376
12,996
Net Operating Cash Flow
37,304
142,775
174,281
136,234
108,439
92,033
Capital Expenditures
54,514
94,630
69,397
52,962
38,008
Sale of Fixed Assets & Businesses
11,947
453
12,550
2,403
139
Purchase/Sale of Investments
120,098
140,246
60,408
49,352
137,166
Net Investing Cash Flow
161,368
21,278
5,967
96,792
108,568
Cash Dividends Paid - Total
42,238
42,254
48,468
43,889
46,420
Issuance/Reduction of Debt, Net
143,621
90,000
22,976
80,000
-
Net Financing Cash Flow
100,322
132,200
122,930
15,022
101,766
Net Change in Cash
8,075
6,300
32,788
23,893
111,651
Free Cash Flow
10,193
104,275
147,145
111,468
85,040
Net Assets from Acquisitions
-
33,476
11,771
-
-
Other Sources
3,160
1,489
10,883
3,191
10,254
Change in Capital Stock
31
25
50,239
50,094
50,084
Exchange Rate Effect
15,667
17,003
12,596
527
3,590
Other Uses
1,863
35,360
8,640
71
982

About Daiichi Sankyo Co.

View Profile
Address
Daiichi Sankyo Head Office Bldg, A&B
Tokyo Tokyo 103
Japan
Employees -
Website http://www.daiichisankyo.co.jp
Updated 07/08/2019
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries.